-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

SCHERING-PLOUGH CORPORATION Add to My Watchlist

(NYSE: SGP)

Detailed Quote

Last Price	28.15 (11.03.09 6:40 PM EST)
Change (%)	- (-)
Volume	-
Open	-
Previous Close	28.15
Day's Range	28.15 - 28.15
Bid / Ask	28.17 / 28.20

Intraday

3 Month

6 Month

1 Year

Average Volume	13,945,800	Shares Outstanding	1.64B
52-Week Range	12.85 - 29.75	Market Cap	46.1B
P/E Ratio	18.6	Earnings Per Share	1.51
Dividend	0.26	Yield	0.92

Symbol	Last	Change (%)

Thu, Oct 22, 2009
	Drug stocks fall on earnings reports Drug stocks trended lower early Thursday after several major pharmaceutical makers released mixed third-quarter earnings reports. - MarketWatch
	Schering-Plough's profit dips on merger charges Schering-Plough Corp. reported lower third-quarter earnings early Thursday, due primarily to charges taken for its 2007 acquisition of Organon BioSciences NV and its impending merger with Merck & Co. - MarketWatch
	Merck's quarterly net triples on asset sale Merck reports a big jump in third-quarter net earnings, due primarily to the sale of its interest in the animal health-care company Merial Ltd. Adjusted results and sales exceed consensus forecasts for the blue-chip drugmaker, soon to grow larger with the completion of its merger with Schering-Plough. - MarketWatch
Wed, Oct 21, 2009
	Stocks in focus for Thursday Among the companies whose shares are expected to see active trade in Thursday’s session are AT&T Inc., McDonald's Corp., and Merck & Co. - MarketWatch
Fri, Oct 16, 2009
	Pfizer, Merck may feel pressure from generics Pfizer Inc. and Merck & Co. are both expected to show the effects of increased competition from generic drugs when the two pharmaceutical bellwethers roll out their third-quarter earnings reports next week. - MarketWatch
More Featured Content

Thu, Nov 12, 2009
	Amarin Corp Is First Small Biopharmaceutical Company to Join SAFE-BioPharma Association - Business Wire
Fri, Nov 06, 2009
	"AIM"ING FOR BETTER ASTHMA CARE - PR Newswire
Wed, Nov 04, 2009
	TheFortuneFinancial.com Research Partners Tracking SGP, TSM, ACN, VZ, STSI and ME NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com. - Marketwire
Tue, Nov 03, 2009
	Merck and Schering-Plough to Complete Merger Today - Business Wire
Mon, Nov 02, 2009
	Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C - PR Newswire
More Press Releases

10/22/09		Q3 2009 Earnings Archive for SGP
08/07/09		Shareholder Meeting Schering-Plough Special Shareholder Meeting Archive for SGP
07/21/09		Q2 2009 Earnings Archive for SGP
05/18/09		Shareholder Meeting Schering-Plough Shareholders Meeting Archive for SGP
04/21/09		Q1 2009 Earnings Archive for SGP

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana